Fractyl Health, Inc.
NASDAQ: GUTS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Harith Rajagopalan
- Employees
- 102
- Headquarters
- Burlington, United States
- IPO year
- 2024
- Market cap
- $56.0M
- Website
- https://fractyl.com
Loading GUTS…
Loading profile data…Frequently asked questions about GUTS
What does Fractyl Health, Inc. (GUTS) do?
Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D an...
Where does GUTS trade?
Fractyl Health, Inc. (GUTS) trades on the NASDAQ.
What sector is GUTS in?
Fractyl Health, Inc. (GUTS) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Fractyl Health, Inc.?
Harith Rajagopalan is the chief executive officer of Fractyl Health, Inc. (GUTS).
Where is Fractyl Health, Inc. headquartered?
Fractyl Health, Inc. is headquartered in United States.
Does GUTS pay a dividend?
Fractyl Health, Inc. (GUTS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did GUTS go public?
Fractyl Health, Inc. (GUTS) completed its initial public offering in 2024.